Figure F-170 is titled “Rate of insomnia topiramate compared with placebo.” The figure displays a forest plot reporting the risk difference of insomnia for topiramate compared with placebo, sertraline. The forest plot depicts a higher rate of insomnia among patients treated with topiramate (2 trials, risk difference 0.12, 95% CI −0.05 to 0.28, I2=0.0%) compared with placebo.

Figure F-170Rate of insomnia for topiramate compared with placebo

Timing of outcome assessment: 12 weeks for all included studies.

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.